As this decision explains, to state a claim attacking a merger on the basis that the Board acted in bad faith you need more than accusations that directors were motivated to avoid a proxy fight involving an activist investor. Informed stockholder approval, disinterested directors, careful consideration, a premium price, reasonable deal protection devices, and prominent advisors all work to negate inferences of bad faith.